Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q79983690 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000052.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q79983690 | ||
| 024 | ‡a 0000-0002-9281-6255 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q79983690 | ||
| 100 | 0 | ‡a Carmen García-Vázquez ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Carmen García-Vázquez ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Altered Expression of Neurotransmitter Receptors and Neuromediators in Vernal Keratoconjunctivitis | ||
| 670 | ‡a Author's Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model. | ||
| 670 | ‡a Author's Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. | ||
| 670 | ‡a Author's Cytokine and chemokine levels in tears from healthy subjects | ||
| 670 | ‡a Author's Cytokine and chemokine tear levels in patients with uveitis. | ||
| 670 | ‡a Author's Effect of TGF-β on ocular surface epithelial cells. | ||
| 670 | ‡a Author's Gene Expression-Based Predictive Models of Graft Versus Host Disease-Associated Dry Eye. | ||
| 670 | ‡a Author's Impression cytology of the ocular surface: a review. | ||
| 670 | ‡a Author's Prehematopoietic Stem Cell Transplantation Tear Cytokines as Potential Susceptibility Biomarkers for Ocular Chronic Graft-Versus-Host Disease. | ||
| 670 | ‡a Author's RNA Collection From Human Conjunctival Epithelial Cells Obtained With a New Device for Impression Cytology | ||
| 670 | ‡a Author's Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial | ||
| 670 | ‡a Author's Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease | ||
| 909 | ‡a (orcid) 0000000292816255 ‡9 1 | ||
| 919 | ‡a alteredexpressionofneurotransmitterreceptorsandneuromediatorsinvernalkeratoconjunctivitis ‡A Altered Expression of Neurotransmitter Receptors and Neuromediators in Vernal Keratoconjunctivitis ‡9 1 | ||
| 919 | ‡a biomarkersinocularchronicgraftversushostdiseasetearcytokineandchemokinebasedpredictivemodel ‡A Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model. ‡9 1 | ||
| 919 | ‡a chitosannanoparticlesasapotentialdrugdeliverysystemfortheocularsurfacetoxicityuptakemechanismandinvivotolerance ‡A Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. ‡9 1 | ||
| 919 | ‡a cytokineandchemokinelevelsintearsfromhealthysubjects ‡A Cytokine and chemokine levels in tears from healthy subjects ‡9 1 | ||
| 919 | ‡a cytokineandchemokinetearlevelsinpatientswithuveitis ‡A Cytokine and chemokine tear levels in patients with uveitis. ‡9 1 | ||
| 919 | ‡a effectoftgfβonocularsurfaceepithelialcells ‡A Effect of TGF-β on ocular surface epithelial cells. ‡9 1 | ||
| 919 | ‡a tearcytokineandchemokineanalysisandclinicalcorrelationsinevaporativetypedryeyedisease ‡A Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease ‡9 1 | ||
| 919 | ‡a geneexpressionbasedpredictivemodelsofgraftversushostdiseaseassociateddryeye ‡A Gene Expression-Based Predictive Models of Graft Versus Host Disease-Associated Dry Eye. ‡9 1 | ||
| 919 | ‡a impressioncytologyoftheocularsurfaceareview ‡A Impression cytology of the ocular surface: a review. ‡9 1 | ||
| 919 | ‡a prehematopoieticstemcelltransplantationtearcytokinesaspotentialsusceptibilitybiomarkersforocularchronicgraftversushostdisease ‡A Prehematopoietic Stem Cell Transplantation Tear Cytokines as Potential Susceptibility Biomarkers for Ocular Chronic Graft-Versus-Host Disease. ‡9 1 | ||
| 919 | ‡a rnacollectionfromhumanconjunctivalepithelialcellsobtainedwithanewdeviceforimpressioncytology ‡A RNA Collection From Human Conjunctival Epithelial Cells Obtained With a New Device for Impression Cytology ‡9 1 | ||
| 919 | ‡a severitytherapeuticandactivitytearbiomarkersindryeyediseaseananalysisfromaphase3clinicaltrial ‡A Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial ‡9 1 | ||
| 996 | ‡2 BNC|981060931443606706 | ||
| 996 | ‡2 BNE|XX967927 | ||
| 996 | ‡2 DNB|1122063458 | ||
| 996 | ‡2 PTBNP|156244 | ||
| 996 | ‡2 NTA|07030114X | ||
| 996 | ‡2 BNF|15967329 | ||
| 996 | ‡2 BNE|XX1540988 | ||
| 996 | ‡2 LC|n 2023050978 | ||
| 996 | ‡2 BNE|XX1393272 | ||
| 996 | ‡2 ISNI|0000000060980136 | ||
| 996 | ‡2 BNE|XX962248 | ||
| 996 | ‡2 LC|n 99800162 | ||
| 996 | ‡2 BNE|XX954591 | ||
| 996 | ‡2 BNE|XX946954 | ||
| 996 | ‡2 DNB|170183998 | ||
| 996 | ‡2 BNE|XX1163335 | ||
| 996 | ‡2 BNE|XX4851507 | ||
| 996 | ‡2 DNB|170513823 | ||
| 996 | ‡2 ISNI|0000000059547095 | ||
| 996 | ‡2 J9U|987007440487505171 | ||
| 996 | ‡2 ISNI|000000040233803X | ||
| 996 | ‡2 BNE|XX6137649 | ||
| 996 | ‡2 BNC|981058516666306706 | ||
| 996 | ‡2 NSK|000430273 | ||
| 996 | ‡2 ISNI|0000000026914098 | ||
| 996 | ‡2 BNF|16918807 | ||
| 996 | ‡2 ISNI|0000000072916764 | ||
| 996 | ‡2 DNB|1158293712 | ||
| 996 | ‡2 BNE|XX1760683 | ||
| 996 | ‡2 BNE|XX1225879 | ||
| 996 | ‡2 SELIBR|fxdrg7j5cd78mlb0 | ||
| 996 | ‡2 NUKAT|n 2016171403 | ||
| 996 | ‡2 ISNI|0000000059558771 | ||
| 996 | ‡2 SUDOC|170971406 | ||
| 996 | ‡2 SUDOC|11870852X | ||
| 996 | ‡2 RERO|A006448057 | ||
| 996 | ‡2 BNC|981058612970406706 | ||
| 996 | ‡2 NKC|xx0254284 | ||
| 996 | ‡2 ARBABN|000042854 | ||
| 996 | ‡2 BNE|XX1439667 | ||
| 996 | ‡2 DNB|1264812655 | ||
| 996 | ‡2 CAOONL|ncf11367355 | ||
| 996 | ‡2 BNCHL|10000000000000000118034 | ||
| 996 | ‡2 BNE|XX1078183 | ||
| 996 | ‡2 ISNI|000000006087005X | ||
| 996 | ‡2 LC|n 2012027911 | ||
| 996 | ‡2 BNE|XX1639632 | ||
| 996 | ‡2 SUDOC|279846800 | ||
| 996 | ‡2 BNE|XX1552751 | ||
| 996 | ‡2 LC|nr 97008681 | ||
| 996 | ‡2 BNF|16912960 | ||
| 996 | ‡2 BNE|XX882548 | ||
| 996 | ‡2 BNC|981058522293506706 | ||
| 996 | ‡2 DNB|1245807048 | ||
| 996 | ‡2 ISNI|0000000055256178 | ||
| 996 | ‡2 BNC|981058602726806706 | ||
| 996 | ‡2 ISNI|000000005930531X | ||
| 996 | ‡2 BNE|XX926866 | ||
| 996 | ‡2 ISNI|0000000060224605 | ||
| 996 | ‡2 ISNI|000000007696945X | ||
| 996 | ‡2 DNB|105742997X | ||
| 996 | ‡2 BNE|XX4849659 | ||
| 996 | ‡2 BNE|XX1296723 | ||
| 996 | ‡2 DNB|1057366951 | ||
| 996 | ‡2 DNB|1203818580 | ||
| 996 | ‡2 CAOONL|ncf11511559 | ||
| 996 | ‡2 BNC|981058614485906706 | ||
| 996 | ‡2 PTBNP|1675545 | ||
| 996 | ‡2 NTA|408509279 | ||
| 996 | ‡2 ISNI|0000000434961205 | ||
| 996 | ‡2 BIBSYS|90404062 | ||
| 996 | ‡2 PTBNP|1460656 | ||
| 996 | ‡2 LC|n 2009074196 | ||
| 996 | ‡2 BNC|981058612473406706 | ||
| 996 | ‡2 BIBSYS|90773129 | ||
| 996 | ‡2 SUDOC|164083278 | ||
| 996 | ‡2 LC|nr2005021443 | ||
| 996 | ‡2 RERO|A026819940 | ||
| 996 | ‡2 DNB|1279722010 | ||
| 996 | ‡2 LC|n 96041182 | ||
| 996 | ‡2 LC|n 00087551 | ||
| 996 | ‡2 DNB|171822390 | ||
| 996 | ‡2 BNF|17772726 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
